Zoetis (ZTS) Long-Term Deferred Tax (2012 - 2026)
Zoetis (ZTS) posted quarterly Long-Term Deferred Tax of $591.0 million for Q1 2026, up 11.51% year-over-year from $530.0 million in Q1 2025, and down 7.08% quarter-over-quarter from $636.0 million in Q4 2025.
Zoetis (ZTS) Long-Term Deferred Tax (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Long-Term Deferred Tax for 15 consecutive years, with $591.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Long-Term Deferred Tax rose 11.51% year-over-year to $591.0 million; the TTM figure through Mar 2026 stood at $591.0 million (up 11.51% YoY), while the FY2025 annual figure was $636.0 million, up 17.78% from the prior year.
- Long-Term Deferred Tax fell to $591.0 million in Q1 2026 per ZTS's latest filing, from $636.0 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $636.0 million in Q4 2025 and bottomed at $103.0 million in Q1 2022.
- Historically, Long-Term Deferred Tax has averaged $338.5 million across 5 years, with a median of $232.0 million in 2024.
- Annual changes were most pronounced in 2022 — Long-Term Deferred Tax advanced 0.91% — and 2024, when it surged 162.14%.
- Zoetis' Long-Term Deferred Tax stood at $173.0 million in 2022, then climbed by 19.08% to $206.0 million in 2023, then soared by 162.14% to $540.0 million in 2024, then rose by 17.78% to $636.0 million in 2025, then dropped by 7.08% to $591.0 million in 2026.
- Business Quant data shows ZTS's Long-Term Deferred Tax at $591.0 million in Q1 2026, $636.0 million in Q4 2025, and $587.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 617.00 Mn |
| Mar 31, 2026 | 591.00 Mn |
| Dec 31, 2025 | 636.00 Mn |
| Sep 30, 2025 | 587.00 Mn |
| Jun 30, 2025 | 617.00 Mn |
| Mar 31, 2025 | 530.00 Mn |
| Dec 31, 2024 | 540.00 Mn |
| Sep 30, 2024 | 409.00 Mn |
| Jun 30, 2024 | 366.00 Mn |
| Mar 31, 2024 | 232.00 Mn |
| Dec 31, 2023 | 206.00 Mn |
| Sep 30, 2023 | 190.00 Mn |
| Jun 30, 2023 | 192.00 Mn |
| Mar 31, 2023 | 161.00 Mn |
| Dec 31, 2022 | 173.00 Mn |
| Sep 30, 2022 | 111.00 Mn |
| Jun 30, 2022 | 110.00 Mn |
| Mar 31, 2022 | 103.00 Mn |
| Dec 31, 2021 | 100.00 Mn |
| Sep 30, 2021 | 110.00 Mn |